P05067 (A4_HUMAN) Homo sapiens (Human)

Amyloid-beta precursor protein UniProtKBInterProSTRINGInteractive Modelling

770 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11); 1 identical sequence: Homo sapiens: A0A140VJC8

Available Structures

160 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with Kunitz Protease … Heteromer
P03951;
289-345
Assess
RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN Heteromer
P00763;
287-342
Assess
Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human… Heteromer
Q92876;
289-343
Assess
Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human… Heteromer
Q92876;
289-343
Assess
BOVINE TRYPSIN COMPLEXED TO APPI Heteromer
P00760;
CA;289-342
Assess
BOVINE CHYMOTRYPSIN COMPLEXED TO APPI Heteromer
P00766;
289-342
Assess
Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI) Heteromer
P35030;
FMT;CA;290-341
Assess
Structure of Human Mesotrypsin in complex with APPI variant T11V/M17R/I18F/F34V Heteromer
P35030;
EDO;294-343
Assess
Human Mesotrypsin in complex with amyloid precursor protein inhibitor variant APPI-M17G/I18F/F34V Heteromer
P35030;
294-342
Assess
Recognition of the Amyloid Precursor Protein by Human gamma-secretase Heteromer
P49768; Q92542; Q96BI3; Q9NZ42;
NAG;NAG;NAG;PC1;CLR;688-726
Assess
Crystal structure of the intracellular domain of human APP in complex with Fe65-PTB2 Heteromer
O00213;
741-768
Assess
Crystal structure of the intracellular domain of human APP (T668A mutant) in complex with Fe65-PTB2 Heteromer
O00213;
742-768
Assess
Crystal structure of the intracellular domain of human APP (T668E mutant) in complex with Fe65-PTB2 Heteromer
O00213;
742-768
Assess
Structure of Alzheimer Ab peptide in complex with an engineered binding protein Heteromer
687-711
Assess
Crystal structure of human insulin-degrading enzyme in complex with amyloid-beta (1-40) Heteromer
P14735;
DIO;672-694
Assess
Crystal structure of human insulin-degrading enzyme in complex with amyloid-beta (1-42) Heteromer
P14735;
ZN;672-693
Assess
Crystal Structure Analysis of Fab-Bound Human Insulin Degrading Enzyme (IDE) in Complex with Amyloi… Heteromer
P14735;
ZN;672-691
Assess
ANTIBODY C706 IN COMPLEX WTH BETA-AMYLOID PEPTIDE 1-16 Heteromer
SO4;GOL;672-687
Assess
Crystal structure of APP peptide bound rat Mint2 PARM Heteromer
O35431;
754-767
Assess
Crystal structure of an engineered lipocalin (Anticalin US7) in complex with the Alzheimer amyloid … Heteromer
P80188;
687-699
Assess
X11 PTB DOMAIN Heteromer
Q02410;
754-766
Assess
Structure of Pyroglutamate-Abeta-specific Fab c#24 in complex with human Abeta-pE3-18 Heteromer
674-685
Assess
Crystal Structure of the GULP1 PTB domain-APP peptide complex Heteromer
Q9UBP9;
SO4;EDO;755-766
Assess
Crystal structure of crenezumab Fab in complex with Abeta Heteromer
684-695
Assess
CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11 Heteromer
NAG;SO4;672-682
Assess
Crystal structure of an engineered lipocalin (Anticalin H1GA) in complex with the Alzheimer amyloid… Heteromer
P80188;
688-698
Assess
Crystal Structure of mid-region amyloid beta capture by solanezumab Heteromer
P01834; P01857;
687-697
Assess
Fab-antibody complex Heteromer
701-711
Assess
Structure of Pyroglutamate-Abeta-specific Fab c#6 in complex with human Abeta-pE3-12-PEGb Heteromer
SO4;GOL;674-683
Assess
Crystal structure of MMP-2 active site mutant in complex with APP-drived decapeptide inhibitor Heteromer
P08253;
ZN;CA;586-595
Assess
Crystal Structure of Human Presequence Protease in Complex with Amyloid-beta (1-40) Heteromer
Q5JRX3;
ZN;GOL;ACT;686-694
Assess
Crystal structure of the complex formed between Phospholipase A2 with beta-amyloid fragment, Lys-Gl… Heteromer
P60045;
CA;699-706
Assess
Phospholipase A2 Prevents the Aggregation of Amyloid Beta Peptides: Crystal Structure of the Comple… Heteromer
P60045;
CA;672-679
Assess
X-ray structure of amyloid beta peptide:antibody (Abeta1-7:12A11) complex Heteromer
672-678
Assess
Crystal structure of Fab wo2 bound to the n terminal domain of amyloid beta peptide (1-16) Heteromer
A2NHM3; P84751;
673-679
Assess
Crystal structure of Fab WO2 bound to the N terminal domain of Amyloid beta peptide (1-28) Heteromer
A2NHM3; Q811U5;
673-679
Assess
Crystal structure of adaptor protein complex 4 (AP-4) mu4 subunit C-terminal domain, in complex wit… Heteromer
O00189;
GOL;761-767
Assess
PFA1 Fab fragment complexed with Abeta 1-8 peptide Heteromer
A2NHM3;
ACM;GOL;673-679
Assess
Crystal structure of adaptor protein complex 4 (AP-4) mu4 subunit C-terminal domain D190A mutant, i… Heteromer
O00189;
761-767
Assess
Structures of Grb2-SH2 Domain and AICD peptide Complexes Reveal a Conformational Switch and Their F… Heteromer
P62993;
756-762
Assess
Crystal Structure of the Complex Formed Between a New Isoform of Phospholipase A2 with C-terminal A… Heteromer
P60045;
CA;707-713
Assess
Structures of Grb2-SH2 Domain and AICD peptide Complexes Reveal a Conformational Switch and Their F… Heteromer
P62993;
756-762
Assess
PFA2 FAB complexed with Abeta1-8 Heteromer
A2NHM3; Q811U5;
NA;673-679
Assess
Crystal Structure of the Complex Formed Between Phospholipase A2 and a Hexapeptide Fragment of Amyl… Heteromer
P60045;
CA;687-692
Assess
X-ray structure of amyloid beta peptide:antibody (Abeta1-40:12A11) complex Heteromer
673-678
Assess
Crystal structure of an engineered lipocalin (Anticalin US7) in complex with the Alzheimer amyloid … Heteromer
P80188;
689-694
Assess
Humanised 3D6 Fab complexed to amyloid beta 1-8 Heteromer
672-677
Assess
Fab fragment of 3D6 in complex with amyloid beta 1-7 Heteromer
672-677
Assess
X-ray structure of amyloid beta peptide:antibody (Abeta1-7:10D5) complex Heteromer
673-678
Assess
Crystal structure of a humanised 3D6 Fab bound to amyloid beta peptide Heteromer
P01834; P01857;
672-677
Assess
Structure of Pyroglutamate-Abeta-specific Fab c#17 in complex with human Abeta-pE3-12PEGb Heteromer
674-679
Assess
aducanumab abeta complex Heteromer
SO4;673-678
Assess
X-ray structure of amyloid beta peptide:antibody (Abeta1-7:12B4) complex Heteromer
673-678
Assess
Alzheimer's Amyloid-Beta Peptide Fragment 29-40 in Complex with Cd-substituted Thermolysin Heteromer
P43133;
CA;CD;DMS;700-704
Assess
Alzheimer's Amyloid-Beta Peptide Fragment 1-40 in Complex with Cd-substituted Thermolysin Heteromer
P43133;
CA;CD;DMS;700-704
Assess
Fab fragment of 3D6 in complex with amyloid beta 1-40 Heteromer
27×ZN;IMD; 11×CL;672-676
Assess
Alzheimer's Amyloid-Beta Peptide Fragment 1-40 in Complex with Thermolysin Heteromer
P00800;
CA;ZN;DMS;702-704
Assess
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 4-10 Heteromer
P12821;
NAG;NAG;NAG;ZN;CL;SO4;PEG;678-680
Assess
Structure of Human Neurolysin (E475Q) in complex with amyloid-beta 35-40 peptide product Heteromer
Q9BYT8;
ZN;CL;709-711
Assess
CryoEM structure of human presequence protease in partial closed state 1 Heteromer
Q5JRX3;
690-692
Assess
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 35-42 Heteromer
P12821;
NAG;NAG;NAG;ZN;CL;PEG;PG4;P6G;712-713
Assess
Atomic model of the Abeta D23N "Iowa" mutant using solid-state NMR, EM and Rosetta modelinghomo-27-mer686-711
Assess
Atomic Resolution Structure of Monomorphic AB42 Amyloid Fibrilshomo-18-mer682-713
Assess
Structural Model for a 40-residue Beta-Amyloid Fibril with Three-Fold Symmetry, Negative Staggerhomo-18-mer680-711
Assess
Structural Model for a 40-residue Beta-Amyloid Fibril with Three-Fold Symmetry, Positive Staggerhomo-18-mer680-711
Assess
Mixing Abeta(1-40) and Abeta(1-42) peptides generates unique amyloid fibrilshomo-16-mer682-713
Assess
Mixing Abeta(1-40) and Abeta(1-42) peptides generates unique amyloid fibrilshomo-16-mer682-713
Assess
A New Structural Model of Abeta(1-40) Fibrilshomo-16-mer682-711
Assess
Abeta fibril (Morphology I)homo-12-mer672-711
Assess
Structural Model for a 40-Residue Beta-Amyloid Fibril with Two-Fold Symmetry, Negative Staggerhomo-12-mer680-711
Assess
Structural Model for a 40-Residue Beta-Amyloid Fibril with Two-Fold Symmetry, Positive Staggerhomo-12-mer680-711
Assess
42-Residue Beta Amyloid Fibrilhomo-12-mer682-713
Assess
Triangular trimer of beta-hairpins derived from Abeta17-36 with an F20Cha mutationhomo-12-mer686-706
Assess
X-ray crystallographic structure of an Abeta 17-36 beta-hairpin. LV(PHI)FAEDCGSNKCAII(SAR)L(ORN)Vhomo-12-mer688-707
Assess
X-ray crystallographic structure of an A-beta 17_36 beta-hairpin. X-ray diffractometer data set. (L…homo-12-merJEF;688-707
Assess
Amyloid Beta KLVFFAENVGS 16-26 D23N Iowa mutationhomo-12-mer687-697
Assess
Structure of an amyloid forming peptide GAIIGL (29-34) from amyloid betahomo-12-mer700-705
Assess
Structure of an amyloid forming peptide KLVFFA from amyloid beta, alternate polymorph IIhomo-12-mer687-692
Assess
Atomic-resolution 3D structure of amyloid-beta fibrils: the Osaka mutationhomo-10-mer672-711
Assess
S8 phosphorylated beta amyloid 40 fibrilshomo-10-mer10×2PO;672-711
Assess
Amyloid-Beta (20-34) with L-isoaspartate 23homo-10-mer691-705
Assess
VGSNKGAIIGL from Amyloid Beta determined by MicroEDhomo-10-mer695-705
Assess
Near-atomic resolution fibril structure of complete amyloid-beta(1-42) by cryo-EMhomo-9-mer672-713
Assess
40-residue beta-amyloid fibril derived from Alzheimer's disease brainhomo-9-mer672-711
Assess
40-residue D23N beta amyloid fibrilhomo-8-mer686-711
Assess
X-ray crystallographic structure of a beta-hairpin peptide derived from amyloid beta 16-36homo-8-merHEZ;685-706
Assess
Structure of amyloid-beta derived peptide - NKGAIFhomo-8-merPO4;698-703
Assess
Amyloid beta oligomer displayed on the alpha hemolysin scaffoldhomo-7-mer672-713
Assess
Atomic resolution structure of a disease-relevant Abeta(1-42) amyloid fibrilhomo-6-mer672-713
Assess
Amyloid-beta(1-40) fibril derived from Alzheimer's disease cortical tissuehomo-6-mer681-711
Assess
Structure of an amyloid forming peptide NKGAII (residues 27-32) from amyloid betahomo-6-mer698-703
Assess
3D Structure of Alzheimer's Abeta(1-42) fibrilshomo-5-mer688-713
Assess
Amyloid-Beta (20-34) wild typehomo-5-mer691-705
Assess
Structure of pore-forming amyloid-beta tetramershomo-4-mer672-713
Assess
Structure of segment MVGGVVIA from the amyloid-beta peptide (Ab, residues 35-42), alternate polymor…homo-4-mer706-713
Assess
Structure of an amyloid forming peptide KLVFFA from amyloid beta in complex with orange Ghomo-4-merORA;687-692
Assess
Structure of segment AIIGLM from the amyloid-beta peptide (Ab, residues 30-35)homo-4-mer701-706
Assess
X-ray crystallographic structure of an A-beta 17_36 beta-hairpin. Synchrotron data set. (LVFFAEDCGS…homo-3-mer688-707
Assess
A receptor moleculehomo-2-merSGN;ZN;CA;GOL;ACT;SCN;SO4;MG;385-624
Assess
The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domainhomo-2-mer371-566
Assess
Crystal Structure Analysis of APP E2 domainhomo-2-merOS;379-559
Assess
Structure of the Heparin-induced E1-Dimer of the Amyloid Precursor Protein (APP)homo-2-merBU4;SO4;ACT;26-190
Assess
X-RAY CRYSTAL STRUCTURE OF THE PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLOID BETA-PROTEIN PRECUR…homo-2-mer287-342
Assess
Dimeric structure of transmembrane domain of amyloid precursor protein in micellar environmenthomo-2-mer686-726
Assess
Solution NMR structure of transmembrane domain of amyloid precursor protein V44Mhomo-2-mer699-726
Assess
Solution NMR structure of transmembrane domain of amyloid precursor protein WThomo-2-mer699-726
Assess
Electron cryo-microscopy of an Abeta(1-42)amyloid fibrilhomo-2-mer686-713
Assess
Beta hairpin derived from Abeta17-36 with an F20Cha mutationhomo-2-merCL;NA;686-706
Assess
Zinc induced dimer of the metal binding domain 1-16 of human amyloid beta-peptide with Alzheimer's …homo-2-merZN;672-687
Assess
Zinc bound dimer of the fragment of human amyloid-beta peptide with Alzheimer's disease pathogenic …homo-2-merZN;672-681
Assess
Structure of segment MVGGVVIA from the amyloid-beta peptide (Ab, residues 35-42), alternate polymor…homo-2-mer706-713
Assess
X-ray structure of the E2 domain of the human amyloid precursor protein (APP) in complex with coppermonomerACT;CU;CD;384-567
Assess
X-ray structure of the E2 domain of the human amyloid precursor protein (APP) in complex with zincmonomerACT;ZN;CD;385-567
Assess
X-ray structure of the E2 domain of the human amyloid precursor protein (APP) in complex with cadmi…monomerACT;CD;388-567
Assess
HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE E1-DOMAIN of THE AMYLOID PRECURSOR PROTEINmonomer28-189
Assess
Solution structure of CAPPD*, an independently folded extracellular domain of human Amyloid-beta Pr…monomer460-569
Assess
The longer crystal structure of the grow factor like domain from Beta amypoid precusor protein (APP…monomer22-126
Assess
Crystal structure of the N-terminal, growth factor-like domain of the amyloid precursor protein bou…monomerCU;GOL;23-123
Assess
N-TERMINAL DOMAIN OF THE AMYLOID PRECURSOR PROTEINmonomer28-123
Assess
Structure of the Alzheimer's disease amyloid precursor protein copper binding domainmonomer124-189
Assess
Structure of the Alzheimer's Amyloid Precursor Protein (APP) Copper Binding Domain (Residues 126- 1…monomer126-189
Assess
Structure of the Alzheimer's Amyloid Precursor Protein (APP) Copper Binding Domain in 'small unit c…monomerGOL;133-189
Assess
Structure of the Alzheimer's Amyloid Precursor Protein (APP) Copper Binding Domain in 'small unit c…monomerCU;133-189
Assess
Structure of the Alzheimer's Amyloid Precursor Protein (APP) copper binding domain (residues 133 to…monomer133-189
Assess
Structure of the Alzheimer's Amyloid Precursor Protein (APP) Copper Binding Domain in 'small unit c…monomerCU1;133-189
Assess
Structure of the Alzheimer's Amyloid Precursor Protein (APP) Copper Binding Domain in 'large unit c…monomerCU;133-189
Assess
Dynamic complex between all-D-enantiomeric peptide D3 with L723P mutant of amyloid precursor protei…monomer672-726
Assess
Dynamic complex between all-D-enantiomeric peptide D3 with wild-type amyloid precursor protein 672-…monomer672-726
Assess
The solution NMR structure of the transmembrane C-terminal domain of the amyloid precursor protein …monomer683-728
Assess
Aqueous Solution Structure of the Alzheimer's Disease Abeta Peptide (1-42)monomer672-713
Assess
Solution structure of the Alzheimer's disease amyloid beta-peptide (1-42)monomer672-713
Assess
Solution structure of the amyloid beta-peptide (1-42)monomer672-713
Assess
Structure of amyloid precursor protein's transmembrane domainmonomer686-726
Assess
THE ALZHEIMER`S DISEASE AMYLOID A4 PEPTIDE (RESIDUES 1-40)monomer672-711
Assess
SOLUTION STRUCTURE OF THE METHIONINE-OXIDIZED AMYLOID BETA-PEPTIDE (1-40). DOES OXIDATION AFFECT CO…monomer672-711
Assess
3D NMR structure of a complex between the amyloid beta peptide (1-40) and the polyphenol epsilon-vi…monomer23Y;672-711
Assess
A partially folded structure of amyloid-beta(1 40) in an aqueous environmentmonomer672-711
Assess
3D NMR structure of a complex between the amyloid beta peptide (1-40) and the polyphenol epsilon-vi…monomer23Y;672-711
Assess
THE SOLUTION STRUCTURE OF AMYLOID BETA-PEPTIDE (1-40) IN A WATER-MICELLE ENVIRONMENT. IS THE MEMBRA…monomer672-711
Assess
Solution NMR Structure of APP TMDmonomer697-726
Assess
Solution NMR Structure of APP G38L mutant TMDmonomer697-726
Assess
Solution NMR Structure of APP G38P mutant TMmonomer697-726
Assess
Solution NMR Structure of APP V44M mutant TMDmonomer697-726
Assess
Solution NMR Structure of APP I45T mutant TMDmonomer697-726
Assess
SOLUTION NMR STRUCTURE OF AMYLOID BETA[E16], RESIDUES 1-28, 14 STRUCTURESmonomer672-699
Assess
SOLUTION STRUCTURE OF RESIDUES 1-28 OF THE AMYLOID BETA-PEPTIDEmonomer672-699
Assess
SOLUTION NMR STRUCTURE OF AMYLOID BETA[F16], RESIDUES 1-28, 15 STRUCTURESmonomer672-699
Assess
SOLUTION STRUCTURE OF RESIDUES 1-28 OF THE AMYLOID BETA-PEPTIDEmonomer672-699
Assess
ALZHEIMER'S DISEASE AMYLOID-BETA PEPTIDE (RESIDUES 10-35)monomer681-706
Assess
Amyloid beta(18-41) peptide fusion with new antigen receptor variable domain from sharksmonomer689-712
Assess
NMR structure of the soluble A beta 17-34 peptidemonomer688-705
Assess
Zinc-binding domain of Alzheimer's disease amyloid beta-peptide in water solution at pH 6.5monomer672-687
Assess
Zinc-binding domain of Alzheimer's disease amyloid beta-peptide in TFE-water (80-20) solutionmonomer672-687
Assess
Zinc-binding domain of Alzheimer's disease amyloid beta-peptide complexed with a zinc (II) cationmonomerZN;672-687
Assess
AMYLOID BETA PEPTIDE (25-35), NMR, 20 STRUCTURESmonomer696-706
Assess
NMR analysis of 25-35 fragment of beta amyloid peptidemonomer696-706
Assess
NMR structure of the fragment 25-35 of beta amyloid peptide in 20/80 v:v hexafluoroisopropanol/wate…monomer696-706
Assess
Solution structure of fragment (25-35) of beta amyloid peptide in SDS micellar solutionmonomer696-706
Assess
Structure of segment KLVFFA from the amyloid-beta peptide (Ab, residues 16-21), alternate polymorph…monomerACT;687-692
Assess
Structure of segment KLVFFA from the amyloid-beta peptide (Ab, residues 16-21), alternate polymorph…monomer687-692
Assess

4 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
homo-2-merBU4;0.713ktm.1.A26-189
100.00
Assess
homo-2-mer0.701aap.1.A289-342
100.00
Assess
homo-2-merSGN;ZN;MG;0.555buo.1.A385-624
100.00
Assess
monomer0.522roz.1.A739-770
100.00
Assess

33 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2homo-2-merBU4;0.723ktm.1.A26-189
100.00
Assess
Isoform 3homo-2-mer0.743nyl.1.B296-491
100.00
Assess
Isoform 3homo-2-merBU4;0.723ktm.1.A26-189
100.00
Assess
Isoform 3monomer0.622yt0.1.A646-677
100.00
Assess
Isoform 3monomer0.556iyc.1.E606-633
98.70
Assess
Isoform 4homo-2-merSGN;ZN;MG;0.735buo.1.A310-549
100.00
Assess
Isoform 4homo-2-merBU4;0.693ktm.1.A26-189
100.00
Assess
Isoform 4monomer0.552yt0.1.A664-695
100.00
Assess
Isoform 5homo-2-mer0.743nyl.1.B315-510
100.00
Assess
Isoform 5homo-2-merBU4;0.683ktm.1.A26-189
100.00
Assess
Isoform 5monomer0.526iyc.1.E625-652
98.70
Assess
Isoform 5monomer0.522roz.1.A665-696
100.00
Assess
Isoform 6homo-2-merSGN;ZN;MG;0.715buo.1.A329-568
100.00
Assess
Isoform 6homo-2-merBU4;0.703ktm.1.A26-189
100.00
Assess
Isoform 6monomer0.576iyc.1.E643-670
98.70
Assess
Isoform 7homo-2-mer0.693nyl.1.B352-547
100.00
Assess
Isoform 7homo-2-merBU4;0.693ktm.1.A26-189
100.00
Assess
Isoform 7homo-2-mer0.641aap.1.A288-342
100.00
Assess
Isoform 7monomer0.522roz.1.A702-733
100.00
Assess
Isoform 8homo-2-merBU4;0.713ktm.1.A26-189
100.00
Assess
Isoform 8homo-2-mer0.691aap.1.A288-342
100.00
Assess
Isoform 8homo-2-merSGN;ZN;MG;0.555buo.1.A366-605
100.00
Assess
Isoform 8monomer0.522roz.1.A720-751
100.00
Assess
Isoform 9homo-2-merBU4;0.723ktm.1.A26-189
100.00
Assess
Isoform 9homo-2-mer0.711aap.1.A289-342
100.00
Assess
Isoform 9homo-2-merSGN;ZN;MG;0.585buo.1.A385-624
100.00
Assess
Isoform 9monomer0.522roz.1.A721-752
100.00
Assess
Isoform 10homo-2-mer0.733nyl.1.B240-435
100.00
Assess
Isoform 10homo-2-merBU4;0.673ktm.1.A14-134
95.87
Assess
Isoform 11homo-2-merBU4;0.713ktm.1.A21-184
100.00
Assess
Isoform 11homo-2-mer0.691aap.1.A283-337
100.00
Assess
Isoform 11homo-2-merSGN;ZN;MG;0.585buo.1.A361-600
100.00
Assess
Isoform 11monomer0.522roz.1.A715-746
100.00
Assess

Alignments